Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Female reproductive factors, menopausal hormone use, and Parkinson's disease.

Liu R, Baird D, Park Y, Freedman ND, Huang X, Hollenbeck A, Blair A, Chen H.

Mov Disord. 2014 Jun;29(7):889-96. doi: 10.1002/mds.25771.

2.

Risk factors for Parkinson's disease may differ in men and women: an exploratory study.

Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA.

Horm Behav. 2013 Feb;63(2):308-14. doi: 10.1016/j.yhbeh.2012.05.013.

3.

Male/Female differences in neuroprotection and neuromodulation of brain dopamine.

Bourque M, Dluzen DE, Di Paolo T.

Front Endocrinol (Lausanne). 2011 Sep 30;2:35. doi: 10.3389/fendo.2011.00035.

4.

Hormone replacement therapy and risk for neurodegenerative diseases.

Dye RV, Miller KJ, Singer EJ, Levine AJ.

Int J Alzheimers Dis. 2012;2012:258454. doi: 10.1155/2012/258454.

5.

Gender, brain-derived neurotrophic factor Val66Met, and frequency of methamphetamine use.

Heinzerling KG, Shoptaw S.

Gend Med. 2012 Apr;9(2):112-20. doi: 10.1016/j.genm.2012.02.005.

6.

The impact of clinical and demographic variables on cognitive performance in methamphetamine-dependent individuals in rural South Carolina.

Price KL, DeSantis SM, Simpson AN, Tolliver BK, McRae-Clark AL, Saladin ME, Baker NL, Wagner MT, Brady KT.

Am J Addict. 2011 Sep-Oct;20(5):447-55. doi: 10.1111/j.1521-0391.2011.00164.x.

7.

STX, a novel nonsteroidal estrogenic compound, induces rapid action in primate GnRH neuronal calcium dynamics and peptide release.

Kenealy BP, Keen KL, R√łnnekleiv OK, Terasawa E.

Endocrinology. 2011 Aug;152(8):3182-91. doi: 10.1210/en.2011-0097.

8.

Variants in estrogen-related genes and risk of Parkinson's disease.

Chung SJ, Armasu SM, Biernacka JM, Lesnick TG, Rider DN, Cunningham JM, Maraganore DM.

Mov Disord. 2011 Jun;26(7):1234-42. doi: 10.1002/mds.23604.

9.

Caveolin proteins and estrogen signaling in the brain.

Luoma JI, Boulware MI, Mermelstein PG.

Mol Cell Endocrinol. 2008 Aug 13;290(1-2):8-13. doi: 10.1016/j.mce.2008.04.005. Review.

10.

Gender differences in Parkinson's disease.

Haaxma CA, Bloem BR, Borm GF, Oyen WJ, Leenders KL, Eshuis S, Booij J, Dluzen DE, Horstink MW.

J Neurol Neurosurg Psychiatry. 2007 Aug;78(8):819-24.

11.

Gonadal steroids differentially modulate neurotoxicity of HIV and cocaine: testosterone and ICI 182,780 sensitive mechanism.

Kendall SL, Anderson CF, Nath A, Turchan-Cholewo J, Land CL, Mactutus CF, Booze RM.

BMC Neurosci. 2005 Jun 8;6:40.

Items per page

Supplemental Content

Support Center